Bibliography for Item 2 in BGP: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(6 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
== | ==Used Resources== | ||
*Alonso-Zaldivar, Ricardo, “FDA pledges openness on gene-altered products,” wtop.com, January 15, 2009. Last Accessed March 14, 2009. http://www.wtopnews.com/?nid=106&sid=1575167 | |||
* Beyond Borders: Global Biotechnology report, 2007. Ernst and Young. Available at: http://www.ey.com/global/content.nsf/International/Biotechnology_Library_Beyond_Borders_2007 | |||
*Bio, ''Biotechnology Industry Facts'', http://www.bio.org/speeches/pubs/er/statistics.asp | |||
**sales, revenue, number of companies, and R&D investment by year | |||
*Bio, ''Industry At-a-Glance'', 2009, http://bio.org/ataglance/ | |||
** defines industry, applications, processes and timeline | |||
*Biotech Institute, ''Industry Facts'', 2005, http://www.biotechinstitute.org/what_is/industry_facts.html | |||
** defines key sub-industries of biotech, as well as 'fun facts' about the industry: who regulates it, how much is spent on R&D, etc. No systematic presentation of information | |||
*CNNMoney, ''Biotechnology'', 2009, http://money.cnn.com/data/sectors/Biotechnology/ | |||
** stock ticker for biotech companies | |||
*http://www.hoovers.com/biotechnology-sector/--ID__174--/free-ind-fr-profile-basic.xhtml | * Council for Entrepreneurial Development, "2007 CED North Carolina Venture Report." 2007. | ||
* Gaisford, James D., and Jill E. Hobbs, William A. Kerr, Nicholas Perdikis, Mari D. Plunkett, ''The Economics of Biotechnology. ''Cheltenham, UK. Edward Elgar, 2001. | |||
*Guo, Re-Jing, Baruch Lev, and Nan Zhou, “Competitive Costs of Disclosure by Biotech IPOs” Journal of Accounting Research, Vo. 42 No. 2 May 2004 | |||
*Hoovers: A D&B Company, ''Industry Overview: Biotechnology Sector'' http://www.hoovers.com/biotechnology-sector/--ID__174--/free-ind-fr-profile-basic.xhtml | |||
** describes basic methods, costs, and goals of the biotech industry | ** describes basic methods, costs, and goals of the biotech industry | ||
*http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1 | *IBISWorld, ''Biotechnology'', Mar 11 2009, http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1 | ||
** identifies key products and services, as well as market size and distribution | ** identifies key products and services, as well as market size and distribution | ||
*http:// | * Kalil, Thomas, ''University-Industry Partnerships in the Life Sciences: A University of California, Berkeley Perspective'', in Biotechnology: Essays from its Heartland, Lynn Yarris, ed. San Francisco: BASIC, 2004. | ||
** | |||
*Maggon, Krishnan, ''Pharmaceutical and Biotechnology Industry Overview 2007'', Knol, http://knol.google.com/k/krishan-maggon/pharmaceutical-and-biotechnology/3fy5eowy8suq3/4# | |||
** hard to measure biotech productivity. No clear connection between R&D investment and payoff | |||
* | * McKelvey, Maureen, Annika Rickne and Jens Laage-Hellman, “Stylized facts about innovation processes in modern biotechnology,” in The Economic Dynamics of Modern Biotechnology. Cheltenham, UK: Edward Elgar, 2004. | ||
** | ** Information about innovation processes | ||
* | * Oliver, Amalya L., "University-Based Biotechnology Spin-Offs," in ''Handbook of Bioentrepreneurship'', Holger Patzelt and Thomas Brenner, eds. New York: Springer, 2008 | ||
* | * Oliver, Richard, ''The Coming Biotech Age: The Business of Bio-Materials'', New York: McGraw-Hill, 2000. | ||
*http://rsss.anu.edu.au/~janeth/BiotechInd.html | *Open Source Biotechnology Project, ''Biotechnology industry overview'', 2002 http://rsss.anu.edu.au/~janeth/BiotechInd.html | ||
** major research tools and products | ** major research tools and products | ||
*http://rsss.anu.edu.au/~janeth/IPIndust.html | *Open Source Biotechnology Project, ''Intellectual Property and Industry Structure'', http://rsss.anu.edu.au/~janeth/IPIndust.html, 1999 | ||
** problems of intellectual property regimes in Biotech, with specific reference to anticommons problems in the Agriculture Biotech industry | ** problems of intellectual property regimes in Biotech, with specific reference to anticommons problems in the Agriculture Biotech industry | ||
*http://biz.yahoo.com/ic/515.html | * Pareras, Luis, "Biotech Business Models," ''Healthonomics'', January 6, 2008/. Last Accessed March 13, 2009. Available at: http://www.healthonomics.org/2008/01/biotech-business-models.html | ||
* Penhoet, Ed. "The Biotechnology Industry from Birth to Adolescence", in ''Biotechnology: Essays from its Heartland, ''Lynn Yarris, ed. San Francisco: BASIC, 2004. | |||
* Pisano, Gary P., "Can Science Be a Business? Lessons from Biotech" Harvard Business Review, Oct2006, Vol. 84 Issue 10, p114-125 | |||
* Pisano, Gary P. ''Science Business: The Promise, the Reality, and the Future of Biotech,'' Boston: Harvard Business School Press, 2006. | |||
* Phillips, Theresa, "Biotech Business Models," ''About.com,'' September 19, 2007. Last Accessed March 13, 2009. Available at: [http://biotech.about.com/b/2007/09/19/biotech-business-models.htm http://biotech.about.com/b/2007/09/19/biotech-business-models.htm] | |||
*Yahoo Inc., ''Industry Center - Biotechnology'', 2009 http://biz.yahoo.com/ic/515.html | |||
** stock ticker for biotech companies | ** stock ticker for biotech companies | ||
* | * Jaffe,A . M. Trajtenberg, R. Henderson. 1993. Geographiclo calization of knowledge spillovers as evidenced by patent citations. Quart. J. Econom. 63 577-598. | ||
* | * Robert Kaiser and Michael Liecke, “Regional Knowledge Dynamics in the Biotechnology Industry: A Conceptual Framework for Micro-Level Analysis” University of Munich | ||
* | * Helena Yli-Renko, Erkko Autio, Harry J. Sapienza , “Social Capital, Knowledge Acquisition, and Knowledge Exploitation in Young Technology-Based Firms,” Strategic Management Journal, Vol. 22, No. 6/7, Special Issue: Strategic Entrepreneurship: Entrepreneurial Strategies for Wealth Creation (Jun. - Jul., 2001), pp. 587-613 | ||
* | * Joel A. C. Baum, Tony Calabrese, Brian S. Silverman , “Don't Go It Alone: Alliance Network Composition and Startups' Performance in Canadian Biotechnology,” Strategic Management Journal, Vol. 21, No. 3, Special Issue: Strategic Networks (Mar., 2000), pp. 267-294 | ||
* | *NCBI, "Our Mission," May 21 2004, http://www.ncbi.nlm.nih.gov/About/glance/ourmission.html | ||
* | *NCBI, "Programs and Activities," May 21 2004, http://www.ncbi.nlm.nih.gov/About/glance/programs.html | ||
* | *NCBI, "Human Genome Resources," http://www.ncbi.nlm.nih.gov/genome/guide/human/ | ||
* | *Bownas, Jennifer, "Accessing records in NCBI's sequence databases" U.S. Department of Energy Biological and Environmental Research program, January 2 2003, http://www.ornl.gov/sci/techresources/Human_Genome/posters/chromosome/sequence.shtml | ||
* | *NCBI, "Sequence Identifiers: A Historical Note," June 14 2004, http://www.ncbi.nlm.nih.gov/Sitemap/sequenceIDs.html | ||
* | *NIH, "National Institutes of Health Public Access," http://publicaccess.nih.gov/ | ||
* | *Science Commons, "NIH Mandate Made Permanent" March 17 2009 http://sciencecommons.org/weblog/archives/2009/03/17/nih-mandate-made-permanent/ | ||
* | *NCBI, "The NCBI Handbook" http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=handbook | ||
* | *NIH Working Group on Research Tools, "Report of the National Institutes of Health (NIH) Working Group on Research Tools" June 4 1998, http://www.nih.gov/news/researchtools/ | ||
* | *Trans-NIH Mouse Initiatives, "Frequently Asked Questions (FAQs) and Answers" http://www.nih.gov/science/models/mouse/sharing/5.html | ||
* | *Ladas & Parry "Patentability of Process Claims in the United States," August 14 1996 http://www.ladas.com/Patents/Biotechnology/Durden-ProcessClaims.html | ||
== | ==Unused Resources== | ||
* New York Biotechnology Association, <http://www.nyba.org/> | * New York Biotechnology Association, <http://www.nyba.org/> | ||
Line 112: | Line 141: | ||
*''Common ground on the critical path'' Nature Reviews Drug Discovery Vol. 5, No. 267,April 2006, <http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html> | *''Common ground on the critical path'' Nature Reviews Drug Discovery Vol. 5, No. 267,April 2006, <http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html> | ||
*Friedman, Yali. ''Building Biotechnology'', Thinkbiotech: 2006. <http://www.amazon.com/Building-Biotechnology-Business-Regulations-Politics/dp/0973467665/ref=si3_rdr_bb_product> | *Friedman, Yali. ''Building Biotechnology'', Thinkbiotech: 2006. <http://www.amazon.com/Building-Biotechnology-Business-Regulations-Politics/dp/0973467665/ref=si3_rdr_bb_product> | ||
Line 128: | Line 156: | ||
*Acharya, Rohini, ''The Emergence and Growth of Biotechnology: Experiences in Industrialized and Developing Countries''. Cheltanham, UK: Edward Elgar, 1999. | *Acharya, Rohini, ''The Emergence and Growth of Biotechnology: Experiences in Industrialized and Developing Countries''. Cheltanham, UK: Edward Elgar, 1999. | ||
*Office of Biotechnology Activities, ''Welcome to OBA'', http://oba.od.nih.gov/oba/index.html | *Office of Biotechnology Activities, ''Welcome to OBA'', http://oba.od.nih.gov/oba/index.html | ||
*''Patent Baristas'', http://patentbaristas.com/ | *''Patent Baristas'', http://patentbaristas.com/ | ||
==Navigation== | |||
[[Give an overall picture of the BGP field]]<br> | |||
[[Biotechnology_-_Genomic_and_Proteomics]] |
Latest revision as of 11:23, 3 May 2009
Used Resources
- Alonso-Zaldivar, Ricardo, “FDA pledges openness on gene-altered products,” wtop.com, January 15, 2009. Last Accessed March 14, 2009. http://www.wtopnews.com/?nid=106&sid=1575167
- Beyond Borders: Global Biotechnology report, 2007. Ernst and Young. Available at: http://www.ey.com/global/content.nsf/International/Biotechnology_Library_Beyond_Borders_2007
- Bio, Biotechnology Industry Facts, http://www.bio.org/speeches/pubs/er/statistics.asp
- sales, revenue, number of companies, and R&D investment by year
- Bio, Industry At-a-Glance, 2009, http://bio.org/ataglance/
- defines industry, applications, processes and timeline
- Biotech Institute, Industry Facts, 2005, http://www.biotechinstitute.org/what_is/industry_facts.html
- defines key sub-industries of biotech, as well as 'fun facts' about the industry: who regulates it, how much is spent on R&D, etc. No systematic presentation of information
- CNNMoney, Biotechnology, 2009, http://money.cnn.com/data/sectors/Biotechnology/
- stock ticker for biotech companies
- Council for Entrepreneurial Development, "2007 CED North Carolina Venture Report." 2007.
- Gaisford, James D., and Jill E. Hobbs, William A. Kerr, Nicholas Perdikis, Mari D. Plunkett, The Economics of Biotechnology. Cheltenham, UK. Edward Elgar, 2001.
- Guo, Re-Jing, Baruch Lev, and Nan Zhou, “Competitive Costs of Disclosure by Biotech IPOs” Journal of Accounting Research, Vo. 42 No. 2 May 2004
- Hoovers: A D&B Company, Industry Overview: Biotechnology Sector http://www.hoovers.com/biotechnology-sector/--ID__174--/free-ind-fr-profile-basic.xhtml
- describes basic methods, costs, and goals of the biotech industry
- IBISWorld, Biotechnology, Mar 11 2009, http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1
- identifies key products and services, as well as market size and distribution
- Kalil, Thomas, University-Industry Partnerships in the Life Sciences: A University of California, Berkeley Perspective, in Biotechnology: Essays from its Heartland, Lynn Yarris, ed. San Francisco: BASIC, 2004.
- Maggon, Krishnan, Pharmaceutical and Biotechnology Industry Overview 2007, Knol, http://knol.google.com/k/krishan-maggon/pharmaceutical-and-biotechnology/3fy5eowy8suq3/4#
- hard to measure biotech productivity. No clear connection between R&D investment and payoff
- McKelvey, Maureen, Annika Rickne and Jens Laage-Hellman, “Stylized facts about innovation processes in modern biotechnology,” in The Economic Dynamics of Modern Biotechnology. Cheltenham, UK: Edward Elgar, 2004.
- Information about innovation processes
- Oliver, Amalya L., "University-Based Biotechnology Spin-Offs," in Handbook of Bioentrepreneurship, Holger Patzelt and Thomas Brenner, eds. New York: Springer, 2008
- Oliver, Richard, The Coming Biotech Age: The Business of Bio-Materials, New York: McGraw-Hill, 2000.
- Open Source Biotechnology Project, Biotechnology industry overview, 2002 http://rsss.anu.edu.au/~janeth/BiotechInd.html
- major research tools and products
- Open Source Biotechnology Project, Intellectual Property and Industry Structure, http://rsss.anu.edu.au/~janeth/IPIndust.html, 1999
- problems of intellectual property regimes in Biotech, with specific reference to anticommons problems in the Agriculture Biotech industry
- Pareras, Luis, "Biotech Business Models," Healthonomics, January 6, 2008/. Last Accessed March 13, 2009. Available at: http://www.healthonomics.org/2008/01/biotech-business-models.html
- Penhoet, Ed. "The Biotechnology Industry from Birth to Adolescence", in Biotechnology: Essays from its Heartland, Lynn Yarris, ed. San Francisco: BASIC, 2004.
- Pisano, Gary P., "Can Science Be a Business? Lessons from Biotech" Harvard Business Review, Oct2006, Vol. 84 Issue 10, p114-125
- Pisano, Gary P. Science Business: The Promise, the Reality, and the Future of Biotech, Boston: Harvard Business School Press, 2006.
- Phillips, Theresa, "Biotech Business Models," About.com, September 19, 2007. Last Accessed March 13, 2009. Available at: http://biotech.about.com/b/2007/09/19/biotech-business-models.htm
- Yahoo Inc., Industry Center - Biotechnology, 2009 http://biz.yahoo.com/ic/515.html
- stock ticker for biotech companies
- Jaffe,A . M. Trajtenberg, R. Henderson. 1993. Geographiclo calization of knowledge spillovers as evidenced by patent citations. Quart. J. Econom. 63 577-598.
- Robert Kaiser and Michael Liecke, “Regional Knowledge Dynamics in the Biotechnology Industry: A Conceptual Framework for Micro-Level Analysis” University of Munich
- Helena Yli-Renko, Erkko Autio, Harry J. Sapienza , “Social Capital, Knowledge Acquisition, and Knowledge Exploitation in Young Technology-Based Firms,” Strategic Management Journal, Vol. 22, No. 6/7, Special Issue: Strategic Entrepreneurship: Entrepreneurial Strategies for Wealth Creation (Jun. - Jul., 2001), pp. 587-613
- Joel A. C. Baum, Tony Calabrese, Brian S. Silverman , “Don't Go It Alone: Alliance Network Composition and Startups' Performance in Canadian Biotechnology,” Strategic Management Journal, Vol. 21, No. 3, Special Issue: Strategic Networks (Mar., 2000), pp. 267-294
- NCBI, "Our Mission," May 21 2004, http://www.ncbi.nlm.nih.gov/About/glance/ourmission.html
- NCBI, "Programs and Activities," May 21 2004, http://www.ncbi.nlm.nih.gov/About/glance/programs.html
- NCBI, "Human Genome Resources," http://www.ncbi.nlm.nih.gov/genome/guide/human/
- Bownas, Jennifer, "Accessing records in NCBI's sequence databases" U.S. Department of Energy Biological and Environmental Research program, January 2 2003, http://www.ornl.gov/sci/techresources/Human_Genome/posters/chromosome/sequence.shtml
- NCBI, "Sequence Identifiers: A Historical Note," June 14 2004, http://www.ncbi.nlm.nih.gov/Sitemap/sequenceIDs.html
- NIH, "National Institutes of Health Public Access," http://publicaccess.nih.gov/
- Science Commons, "NIH Mandate Made Permanent" March 17 2009 http://sciencecommons.org/weblog/archives/2009/03/17/nih-mandate-made-permanent/
- NCBI, "The NCBI Handbook" http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=handbook
- NIH Working Group on Research Tools, "Report of the National Institutes of Health (NIH) Working Group on Research Tools" June 4 1998, http://www.nih.gov/news/researchtools/
- Trans-NIH Mouse Initiatives, "Frequently Asked Questions (FAQs) and Answers" http://www.nih.gov/science/models/mouse/sharing/5.html
- Ladas & Parry "Patentability of Process Claims in the United States," August 14 1996 http://www.ladas.com/Patents/Biotechnology/Durden-ProcessClaims.html
Unused Resources
- New York Biotechnology Association, <http://www.nyba.org/>
- Think Biotech, <http://www.thinkbiotech.com/>
- D&B Sales & Marketing Solutions, Searching for Biotechnology Companies?, http://trial.selectory.com/google/mtw_biotechnology_company.html?registrationcode=goog0841&RepCode=MTW&LeadDest=DNB
- Think Biotech, Biotech-U: Web-based courses in biotechnology, <http://www.biotech-u.com/courses/?>
- DMOZ, Biotechnology and Pharmaceuticals, <http://www.dmoz.org/Business/Biotechnology_and_Pharmaceuticals/>
- Journal of Commercial Biotechnology, http://www.palgrave-journals.com/jcb/index.html
- Biocentury, <http://www.biocentury.com/BCApp/BioCenturyCommon/BCAbout.aspx?ss=2>
- Provides corporate reports
- Bioentrepreneur, <http://www.nature.com/bioent/index.html>
- Drug Patent Watch, Pharmaceutical Innovation Dashboard, <http://www.drugpatentwatch.com/innovation/>
- Nature Reviews: Drug Discovery, Common ground on the critical path April 2006, <http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html>
- Gower, J M, The evolving role of collaboration in biotechnology Nature Biotechnology Vol 16, p. 31-32, <http://www.nature.com/bioent/building/partnering/012003/full/nbt0598supp_31.html>
- Brazley, Kevin, "Not enough biotechs, and what government can do about it" Nature Biotechnology Vol. 17, p. 35-36, <http://www.nature.com/bioent/building/regional/012003/full/nbt0599supp_35.html>
- Gross, Clifford U2B: A new model for technology transfer 23 June 2003, http://www.nature.com/bioent/building/tech/062003/full/bioent739.html
- Daizadeh, Iraj Journal of Commercial Biotechnology "Using intellectual property to map the organisational evolution of firms" 2006 vol. 13, p. 28-36 http://www.palgrave-journals.com/jcb/journal/v13/n1/abs/3050032a.html
- Raubicheck, Charles J, Barry S White, Thomas J Kowalski, Daniel G Brown, Amy Leahy Pamela Fekete Integra: The research tool patent revival Journal of Commercial Biotechnology 2003 Vol. 10, p. 162-166, <http://www.palgrave-journals.com/jcb/journal/v10/n2/abs/3040070a.html>
- Harlin , Michael B & Kevin A O'Connor Leveraging your biotech intellectual property Biontrepreneur, April 24 2008 <http://www.nature.com/bioent/2008/080401/full/bioe.2008.5.html>
- Sparey, Tim & Francesca Gliubich Learning from each other, Biontrepreneur, April 10 2008, <http://www.nature.com/bioent/2008/080401/full/bioe.2008.4.html>
- Pratt, Michael, and Christopher Harris, Utopia, karma, and reality: three views on sharing resources among multiple institutions, Bioentrepreneur July 25 2005, <http://www.nature.com/bioent/building/tech/072005/full/bioent869.html>
- Gogoris, Adda and Pamela Ancora, Research tool patents: tips for facing a "pay up now or litigate" ultimatum Nature Biotechnology Vol. 19, p. 1075-1077, <http://www.nature.com/bioent/building/ip/012003/full/nbt1101-1075.html>
- Hodgson, John, The headache of knowledge management, Nature Biotechnology Vol. 19, <http://www.nature.com/bioent/building/infra/012003/full/nbt0601supp_BE44.html>
- Alper, John The Money Men Bioentrepreneur May 23 2003, <http://www.nature.com/bioent/view/052003/full/bioent733.html>
- Praiss, Donna, Creating a winning patent portfolio, Nature Biotechnology Vol. 19, <http://www.nature.com/bioent/building/ip/012003/full/nbt0601supp_BE5.html>
- Anderegg, Marcia H and Joshua M Thayer and Kathleen M Williams Trendspotting: a shift in intellectual property focus, Bioentrepreneur, April 24 2006 <http://www.nature.com/bioent/building/ip/042006/full/bioent907.html>
- Common ground on the critical path Nature Reviews Drug Discovery Vol. 5, No. 267,April 2006, <http://www.nature.com/nrd/journal/v5/n4/abs/nrd2019.html>
- Friedman, Yali. Building Biotechnology, Thinkbiotech: 2006. <http://www.amazon.com/Building-Biotechnology-Business-Regulations-Politics/dp/0973467665/ref=si3_rdr_bb_product>
- McKelvey, Maureen, The Economic Dynamics of Modern Biotechnology. Cheltenham, UK: Edward Elgar, 2004. <http://books.google.com/books?id=oxSNWloXXVAC&pg=PA54&dq=Open+Business+in+Biotechnology&lr=&ei=oBSvSdKIOKKIyATM5biQBQ#PPR6,M1>
- Ono, Dana, The Business of Biotechnology. 1991. <http://search.barnesandnoble.com/booksearch/isbninquiry.asp?r=1&ean=0750691190>
- Hope, Janet, Biobazaar: The Open Source Revolution. Cambridge: Harvard University Press, 2008. <http://books.google.com/books?id=IPTwYNqpJWgC&pg=PA53&dq=Open+Business+in+Biotechnology&ei=RAKvScnxCZvWzASgmoCJCQ#PPA72,M1>
- Fuchs, Gerald, Biotechnology in Comparative Perspective. Routledge, 2004. <http://books.google.com/books?id=B4xBuHH-TmcC&pg=PA181&dq=Open+Business+in+Biotechnology&ei=RAKvScnxCZvWzASgmoCJCQ#PPA29,M1>
- Friedman, Yali. The Business of Biotech. Logos Press, 2008. <http://books.google.com/books?id=-RWJa1KrkusC&pg=PA149&dq=Open+Business+in+Biotechnology&lr=&ei=oBSvSdKIOKKIyATM5biQBQ#PPA186,M1>
- Acharya, Rohini, The Emergence and Growth of Biotechnology: Experiences in Industrialized and Developing Countries. Cheltanham, UK: Edward Elgar, 1999.
- Office of Biotechnology Activities, Welcome to OBA, http://oba.od.nih.gov/oba/index.html
- Patent Baristas, http://patentbaristas.com/
Give an overall picture of the BGP field
Biotechnology_-_Genomic_and_Proteomics